𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacogenetics, pharmacogenomics and personalized psychiatry: Are we there yet?

✍ Scribed by K. Broich; H. J. Möller

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
76 KB
Volume
258
Category
Article
ISSN
1433-8491

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

“Are we there yet?”
“Are we there yet?”
✍ Lisa H. Williams; Gregory J. Raugi; Gurpreet Dhaliwal; Sanjay Saint; Benjamin A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 284 KB

The approach to clinical conundrums by an expert clinician is revealed through presentation of an actual patient's case in an approach typical of morning report. Similar to patient care, sequential pieces of information are provided to the clinician who is unfamiliar with the case. The focus is on t

Melanoma: Are we there yet?
Melanoma: Are we there yet?
✍ Donald L. Morton 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB
Clinical SERS: are we there yet?
Clinical SERS: are we there yet?
✍ Kiang Wei Kho; Chit Yaw Fu; U. S. Dinish; Malini Olivo 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 763 KB

## Abstract Surface Enhanced Raman Spectroscopy or SERS has witnessed many successes over the past 3 decades, owing particularly to its simplicity of use as well as its highly‐multiplexing capability. This article provides an overview of SERS and its applicability in the field of bio‐medicine. We w

Adjuvant aromatase inhibitors : Are we t
Adjuvant aromatase inhibitors : Are we there yet?
✍ Gini F. Fleming 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 50 KB

The current issue contains an update on the results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial. After a median follow‐up period of 47 months, there remains an advantage in terms of disease‐free survival (DFS) for patients treated with anastrozole compared with patients treated w